Literature DB >> 23844332

Association between spinocerebellar ataxias caused by glutamine expansion and psychiatric and neuropsychological signals - a literature review.

Uanda Cristina Almeida-Silva1, Jaime Eduardo Cecílio Hallak, Wilson Marques Júnior, Flávia de Lima Osório.   

Abstract

The autosomal dominant cerebellar ataxias, also known as spinocerebellar ataxias (SCA), are characterized by cerebellar degeneration and by their afferent and efferent connections. Currently, at least 31 types of SCA are described, among which a subset, comprising types 1, 2, 3, 6, 7, 17 of the disease, is distinguished due to sharing the same form of mutation involving the repetition of the series of CAG triplets, known as polyglutamine diseases (SCApolyQ). Through a systematic literature review using the Pubmed, PsycoINFO, LILACS and SciELO databases and the keywords Spinocerebellar Ataxia in association with the words neuropsychiatric, psychological, cognitive impairment(s) and psychiatric comorbidities this study aimed to identify the possible associations between SCApolyQ and neuropsychological and psychiatric symptoms/disorders. A greater presence of symptoms of depression and anxiety was evidenced, as well as the existence of cognitive impairments in the patients with SCApolyQ when compared with the general population, with important differences in the profile of these impairments among the types of SCA. It was observed that the findings, in general, indicated greater impairment in the executive functions, verbal fluency and verbal memory and that there was a higher concentration of studies for SCA2 and SCA3. However, there is a need for a greater number of studies using a more homogeneous methodology, which perform direct comparisons between the types of ataxias and that explore some of the still little evaluated neuropsychological functions and the different psychiatric disorders in their amplitude.

Entities:  

Keywords:  Spinocerebellar ataxia; cognitive aspects; cognitive function; psychiatric aspects

Year:  2013        PMID: 23844332      PMCID: PMC3703120     

Source DB:  PubMed          Journal:  Am J Neurodegener Dis        ISSN: 2165-591X


  35 in total

1.  Neuropsychological picture of 33 spinocerebellar ataxia cases.

Authors:  Laura Orsi; Federico D'Agata; Paola Caroppo; Alessandra Franco; Marcella Maria Caglio; Federica Avidano; Cristina Manzone; Paolo Mortara
Journal:  J Clin Exp Neuropsychol       Date:  2011-02-06       Impact factor: 2.475

2.  Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6.

Authors:  Ina Klinke; Martina Minnerop; Tanja Schmitz-Hübsch; Marc Hendriks; Thomas Klockgether; Ullrich Wüllner; Christoph Helmstaedter
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

3.  Machado-Joseph disease of Azorean ancestry in Brazil: the Catarina kindred. Neurological, neuroimaging, psychiatric and neuropsychological findings in the largest known family, the "Catarina" kindred.

Authors:  J Radvany; C H Camargo; Z M Costa; N C Fonseca; E D Nascimento
Journal:  Arq Neuropsiquiatr       Date:  1993-03       Impact factor: 1.420

4.  The cerebellum and cognition. Intellectual function in spinocerebellar ataxia type 6 (SCA6).

Authors:  C Globas; S Bösch; Ch Zühlke; I Daum; J Dichgans; K Bürk
Journal:  J Neurol       Date:  2003-12       Impact factor: 4.849

5.  Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families.

Authors:  A Dürr; D Smadja; G Cancel; A Lezin; G Stevanin; J Mikol; R Bellance; G G Buisson; H Chneiweiss; J Dellanave
Journal:  Brain       Date:  1995-12       Impact factor: 13.501

6.  Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction.

Authors:  E Storey; S M Forrest; J H Shaw; P Mitchell; R J Gardner
Journal:  Arch Neurol       Date:  1999-01

7.  Executive and emotional dysfunction in Machado-Joseph disease.

Authors:  Tricia M Zawacki; Janet Grace; Joseph H Friedman; Lewis Sudarsky
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338

8.  Cognitive impairment in spinocerebellar ataxia type 6.

Authors:  M Suenaga; Y Kawai; H Watanabe; N Atsuta; M Ito; F Tanaka; M Katsuno; H Fukatsu; S Naganawa; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-06       Impact factor: 10.154

9.  Cognitive deficits in Machado-Joseph disease.

Authors:  P Maruff; P Tyler; T Burt; B Currie; C Burns; J Currie
Journal:  Ann Neurol       Date:  1996-09       Impact factor: 10.422

10.  Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum in two Italian families with spinocerebellar ataxia type 17.

Authors:  G De Michele; F Maltecca; M Carella; G Volpe; M Orio; A De Falco; S Gombia; A Servadio; G Casari; A Filla; A Bruni
Journal:  Neurol Sci       Date:  2003-10       Impact factor: 3.307

View more
  7 in total

Review 1.  Ataxia.

Authors:  Umar Akbar; Tetsuo Ashizawa
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

2.  Cerebellum and Emotion Memory.

Authors:  Melanie Mark; Johanna Pakusch; Thomas M Ernst; Dagmar Timmann
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 3.  Current and emerging treatment modalities for spinocerebellar ataxias.

Authors:  Shaila D Ghanekar; Sheng-Han Kuo; Joseph S Staffetti; Theresa A Zesiewicz
Journal:  Expert Rev Neurother       Date:  2022-02-10       Impact factor: 4.287

4.  Depression and clinical progression in spinocerebellar ataxias.

Authors:  Raymond Y Lo; Karla P Figueroa; Stefan M Pulst; Susan Perlman; George Wilmot; Christopher Gomez; Jeremy Schmahmann; Henry Paulson; Vikram G Shakkottai; Sarah Ying; Theresa Zesiewicz; Khalaf Bushara; Michael Geschwind; Guangbin Xia; Jui-Tsen Yu; Lue-En Lee; Tetsuo Ashizawa; S H Subramony; Sheng-Han Kuo
Journal:  Parkinsonism Relat Disord       Date:  2015-11-22       Impact factor: 4.891

5.  Karyopherin α-3 is a key protein in the pathogenesis of spinocerebellar ataxia type 3 controlling the nuclear localization of ataxin-3.

Authors:  Anna Sergeevna Sowa; Elodie Martin; Inês Morgado Martins; Jana Schmidt; Reinhard Depping; Jonasz Jeremiasz Weber; Franziska Rother; Enno Hartmann; Michael Bader; Olaf Riess; Hervé Tricoire; Thorsten Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-23       Impact factor: 11.205

Review 6.  Ataxia in children: early recognition and clinical evaluation.

Authors:  Piero Pavone; Andrea D Praticò; Vito Pavone; Riccardo Lubrano; Raffaele Falsaperla; Renata Rizzo; Martino Ruggieri
Journal:  Ital J Pediatr       Date:  2017-01-13       Impact factor: 2.638

Review 7.  Standardized Assessment of Hereditary Ataxia Patients in Clinical Studies.

Authors:  Brigitte K Paap; Sandra Roeske; Alexandra Durr; Ludger Schöls; Tetsuo Ashizawa; Sylvia Boesch; Lisa M Bunn; Martin B Delatycki; Paola Giunti; Stéphane Lehéricy; Caterina Mariotti; Jörg Melegh; Massimo Pandolfo; Chantal M E Tallaksen; Dagmar Timmann; Shoji Tsuji; Jörg Bela Schulz; Bart P van de Warrenburg; Thomas Klockgether
Journal:  Mov Disord Clin Pract       Date:  2016-02-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.